L. De Sadeleer (München, Germany), S. Guler (Bern, Switzerland)
Clinical and biological impact of respiratory sleep disorders in IPF
J. Bordas Martinez (Hospitalet de Llobregat (Barcelona), Spain), N. Salord (Hospitalet de Llobregat (Barcelona), Spain), V. Vicens Zygmunt (Hospitalet de Llobregat (Barcelona), Spain), R. Blavia Aloy (Sant Joan Despí, Barcelona, Spain), S. Pérez Ramos (Hospitalet de Llobregat (Barcelona), Spain), E. Prado Gala (Hospitalet de Llobregat (Barcelona), Spain), M. Calvo Sánchez (Hospitalet de Llobregat (Barcelona), Spain), G. Bermudo (Hospitalet de Llobregat (Barcelona), Spain), J. Ríos Martín (Hospitalet de Llobregat (Barcelona), Spain), S. Santos (Hospitalet de Llobregat (Barcelona), Spain), M. Molina-Molina* (Hospitalet de Llobregat (Barcelona), Spain), C. Monasterio* (Hospitalet de Llobregat (Barcelona), Spain)
|   |
Development of scoring system for the prediction of pulmonary complications following curative resection in lung cancer with idiopathic pulmonary
H. Yoo (Seoul, Republic of Korea), Y. Im (Seoul, Republic of Korea), M. Chung (Seoul, Republic of Korea)
| |
Nintedanib in patients with progressive fibrosing ILDs in subgroups by comorbidity burden
E. Bendstrup (Aarhus, Denmark), T. Moua (Rochester, MN, United States), M. Okamoto (Kurume, Japan), S. Tomassetti (Florence, Italy), C. Valenzuela (Madrid, Spain), W. Wuyts (Leuven, Belgium), C. Miede (Sulzbach (Taunus), Germany), D. Lievens (Ingelheim am Rhein, Germany), F. Bonella (Essen, Germany)
| |
Idiopathic pulmonary fibrosis and palliative care: a qualitative exploration of nurses' experiences.
G. O'Sullivan (Cork, Ireland), C. Watson (Dublin, Ireland), B. Murray (Dublin, Ireland)
| |
Triggers and impact of chronic cough in interstitial lung disease
B. Hirons (London, United Kingdom), K. Rhatigan (London, United Kingdom), H. Kesavan (London, United Kingdom), L. Wright (Peterborough, United Kingdom), E. Pelling (Peterborough, United Kingdom), P. Cho (London, United Kingdom), S. Birring (London, United Kingdom)
| |
Neurocognitive impairment in patients with idiopathic pulmonary fibrosis
J. Javorac (Sremska Kamenica, Republic of Serbia), D. Živanovic (Subotica, Republic of Serbia), M. Ilic (Sremska Kamenica, Republic of Serbia), A. Milenkovic (Sremska Kamenica, Republic of Serbia), N. Savic (Sremska Kamenica, Republic of Serbia), M. Cvetkovic (Sremska Kamenica, Republic of Serbia)
| |
Impact of weight loss on outcomes in patients with progressive fibrosing interstitial lung diseases (ILDs)
M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark), T. Maher (Los Angeles, CA, United States), Y. Inoue (Sakai City, Osaka, Japan), C. Miede (Sulzbach (Taunus), Germany), D. Lievens (Ingelheim am Rhein, Germany), B. Crestani (Paris, France)
| |
Effects of influenza vaccination in patients with interstitial lung diseases: an epidemiological claims data analysis
P. Marijic (Neuherberg, Germany), L. Schwarzkopf (Neuherberg, Germany), W. Maier (Neuherberg, Germany), F. Trudzinski (Heidelberg, Germany), L. Schwettmann (Neuherberg, Germany), M. Kreuter (Heidelberg, Germany)
| |
Patients' perceptions of interstitial lung disease (ILD)
V. Joshi (Luton, United Kingdom), A. Reka (Luton, United Kingdom), L. Drummonds (Luton, United Kingdom)
| |
“The will to live!” The perceptions of patients with idiopathic pulmonary fibrosis (IPF) in relation to antifibrotic treatment: a qualitative study
E. Viana Mancuzo (Belo Horizonte (MG), Brazil), L. Neto Generoso (Belo Horizonte (MG), Brazil), T. Mancuzo De Freitas (Belo Horizonte (MG), Brazil), M. Guimaraes Assis (Belo Horizonte (MG), Brazil)
| |
Oesophageal Dysmotility: Does it Play a Role in Interstitial Lung Diseases?
D. Sykes (Hull, United Kingdom), S. Hart (Hull, United Kingdom), M. Crooks (Hull, United Kingdom), W. Jackson (Hull, United Kingdom), J. Gallagher (Hull, United Kingdom), A. Morice (Hull, United Kingdom)
| |
Deterioration of 6-minute walk distance in Idiopathic pleuroparenchymal fibroelastosis is not related to the disease entity
S. Ebihara (Tokyo, Japan), N. Sato (Tokyo, Japan), T. Ebihara (Tokyo, Japan)
| |
Psychological assessment and intervention in IPF patients
L. Rovere (Milano (MI), Italy), S. Pozzi (Milano (MI), Italy), E. De Juli (Milano (MI), Italy), S. Amatucci (Milano (MI), Italy), G. Ziglio (Milano (MI), Italy), P. Tarsia (Milano (MI), Italy), U. Mazza (Milano (MI), Italy)
| |
Impact of intrathoracic pressure in the assessment of central pulmonary pressures in COPD and ILD candidates for lung transplantation.
A. Calabuig (Barcelona, Spain), J. Grignola (Montevideo, Uruguay), C. Bravo (Barcelona, Spain), P. Trujillo (Montevideo, Uruguay), M. López-Messeguer (Barcelona, Spain), E. Domingo (Barcelona, Spain)
| |
Interstitial Lung Disease: The Forgotten Patient
H. Prior (Greater Manchester, United Kingdom), H. Hameed (Greater Manchester, United Kingdom), A. Unsworth (Greater Manchester, United Kingdom), A. Watmough (Greater Manchester, United Kingdom), A. Ashish (Greater Manchester, United Kingdom)
| |
A Comparison of Survival in IPF, Emphysema and CPFE Syndrome
C. Huntley (Birmingham, United Kingdom), M. Armitage (Birmingham, United Kingdom), P. Mitra (Birmingham, United Kingdom), M. Thomas (Birmingham, United Kingdom), P. Burge (Birmingham, United Kingdom), G. Walters (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom)
| |
Loss of muscle mass in Idiopathic Pulmonary Fibrosis
N. Bernardinello (Padova, Italy), S. Petrarulo (Padova, Italy), G. Grisostomi (Padova, Italy), A. Modugno (Padova, Italy), S. Bertin (Padova, Italy), D. Pasin (Padova, Italy), E. Cocconcelli (Padova, Italy), P. Spagnolo (Padova, Italy), C. Giraudo (Padova, Italy), E. Balestro (Padova, Italy)
| |
Late Breaking Abstract - Association between the Use of Statins and Incidence of Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis: A Cohort Study
W. Choi (Goyang-si, Republic of Korea), G. Loloci (Tirana, Albania), D. Lee (Daegu, Republic of Korea), J. Jeong (Daegu, Republic of Korea)
| |
Late Breaking Abstract - The interstitial lung disease (ILD) patient journey in Brazil
A. Rubin (Porto Alegre, Brazil), L. Mota (Brasília, Brazil), R. Scabello (São Paulo, Brazil), C. Cruz (São Paulo, Brazil), H. Silva (São Paulo, Brazil)
| |